Used in pharmaceutical research as a key intermediate in the synthesis of centrally acting agents targeting neurological disorders. Its structure supports binding to monoamine receptors, making it valuable in developing compounds for depression, anxiety, and cognitive diseases. The compound’s ability to cross the blood-brain barrier enhances its utility in CNS drug design. Also investigated for use in radiolabeled forms for neuroimaging studies.